Introducing the world’s first saliva-based PCR test
Songbird was the first company in Canada to offer point of care rapid testing during the height of the pandemic. Now, Songbird is introducing Sal6830, the world’s first saliva-based PCR test, to its range of authorized DNA/RNA-identification technologies.
Authorized by Health Canada and the FDA for emergency use, Sal6830 combines the speed and convenience of an antigen test with the accuracy of a PCR test.
Find out if Sal6830 is right for your workplace.
sample is non-invasive, making testing more comfortable than nasal swabs
Results in under 30 minutes
Returns results in 27
PCR testing where and when it is needed for real-time decision making.
FDA authorized* point-of-care technology captures intact virus, an important
indicator of infection.
Painless sampling Eliminates the need for uncomfortable swab testing.
Self-collected samples Limits worker exposure, decreasing the risk of viral transmission..
Resistant to global supply chain shortages Does not require any additional materials to carry out a test. Proudly developed and manufactured in the United States.
Authorized for emergency use by Health Canada
Authorized for emergency use by the FDA under an EUA for use by authorized laboratories or under a CIA waiver.
Developed with the support from the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (RADx) initiative.